Kalorama Information: Testing for Women's Health an 8 Billion-Dollar Business

NEW YORK, Nov. 18, 2014 /PRNewswire/ -- Kalorama Information estimates the market for women's healthcare diagnostics to be 8.4 billion, according to its latest report.  The report says disease affecting the female population can benefit from earlier detection and tests take the form of imaging, surgical and in vitro approaches.  The finding was made in Kalorama's new report, Diagnostic Markets for Women's Health. 

"Worldwide, women are living longer than men and they are driving healthcare purchases,"  said author Joe Constance.  "Testing ins an increasing part of healthcare and of course that means it's an increasing part of women's health."

The report can be found at http://www.marketresearch.com/redirect.asp?progid=86858&productid=8487406.

According to the report, the women's health area, both therapeutics and diagnostics, has grown considerably as a specialty medical field. Once limited to obstetrics and gynecology, it now includes other fields, such as urology, maternal-fetal medicine, as well as autoimmune disease and cystic fibrosis. At many clinics and practices focused on the health of women, a range of specialties are offered, which often results in a need for specific types of women's health-related testing.

The report cites the following statistics underlying the need for detection of key diseases affecting the female population:

• More women die from heart disease each year than from breast, ovarian, and uterine cancer combined. Heart disease is the number one cause of mortality in women, killing more women than men each year.
• Colorectal cancer is the third leading cause of cancer deaths in women, killing almost 30,000 women each year. Autoimmune diseases are collectively the eighth leading cause of death for women under the age of 65.
• Osteoporosis poses a significant health risk, particularly among women, and the problem is intensifies with age. Osteoporosis is estimated to affect 200 million women worldwide: about 10% of women aged 60; 20% of women aged 70; 40% of women aged 80; more than 65% of women aged 90. The disease impacts approximately 75 million people in Europe, the US and Japan.
• Urinary tract infections are the leading cause of gram-negative bacteremia. In the US, these infections account for approximately 8 million office visits and more than 1 million hospitalizations annually. For women, the lifetime risk of having a UTI is greater than 50%.
• More than 13 million babies experience jaundice annually. More than 9 million of them are born in developing countries.
• Autoimmune disease as a category affects 50 million Americans. It is one of the top ten causes of death in women under the age of 65. Women are more susceptible to the diseases, as they are affected 75% more often than men. The NIH estimates annual direct health care costs for AD to be in the range of $100 billion.

The report, Diagnostic Markets for Women's Health from Kalorama Information contains specific market sizing and forecasts for the pregnancy and ovulation, bone density, prenatal screening, ultrasound, mammography, pap smear, colposcopy, HPV, UTI, and other testing.   For more information on the report, visit: http://www.marketresearch.com/Kalorama-Information-v767/Women-Health-Diagnostic-Testing-8487406/.

About Kalorama Information -- Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.

Contact:
Bruce Carlson
(212) 807-2622
[email protected]
www.KaloramaInformation.com

Logo - http://photos.prnewswire.com/prnh/20140801/132634

SOURCE Kalorama Information